Cancer Data Science Pulse

Artificial Intelligence

Common Data Elements (CDEs) enrich and standardize data through consistent and accurate metadata, helping to make data ready for use in training artificial intelligence (AI) models. In this blog, Ms. Denise Warzel discusses the role of CDEs and AI in CBIIT’s Semantic Infrastructure.

Whether you are in the data science field, interested in developing computational solutions for clinical oncology, or a clinical researcher, we’ve curated a list of data sets, tools, and learning resources to showcase how these disciplines can and are working together to empower cancer research.

Are you interested in using artificial intelligence (AI) in your research or clinical practice but feeling unsure about where to start? Researchers from NCI’s Center for Cancer Research, Drs. Baris Turkbey and Stephanie Harmon, offer five tips that can get you started.

We’re celebrating “Love Data Week” by featuring scientists who love data—especially diverse data. In this blog, scientists tell why they love diverse data and offer tips for increasing diversity in your research data.

Did you know that the same technology that makes your video games more realistic is helping to power important advances in cancer research? This latest blog by Dr. Eric Stahlberg looks at edge computing and how it’s helping to transform cancer research and care.

Read the blogs that topped our charts in 2023, and see if your favorite made #1!

NCI recently hosted a two-day workshop with more than 600 developers, researchers, and data scientists from the United States, Canada, and the European Union. Participants addressed some of the challenges of removing personal information from medical images—a process called de-identification. This blog features highlights from the workshop.

Meet Drs. Ajay Aggarwal and Anant Madabhushi, two grantees funded by NCI’s Center for Global Health’s Affordable Cancer Technologies (ACTs) Program. These ACTs-supported grantees are using artificial intelligence (AI) to develop tools that can be used in a variety of conditions and health systems around the world.

If you can see it, you can treat it. In this blog, Dr. Baris Turkbey, senior clinician in NCI’s Molecular Imaging Branch, Center for Cancer Research, explores the field of theranostics. He describes how artificial intelligence and data are helping researchers “see” cancer in a new way, resulting in a more precise way of targeting cancer treatment.

Dr. Vivian Ota Wang shares her perspectives on data bias and outlines ideas for making data more equitable, fair, and useful to the greatest number of people, all of which would benefit cancer research.